Ehninger G - Search Results

1

The level of residual disease based on mutant NPM1 is an independent prognostic factor for relapse and survival in AML.

Shayegi N, Kramer M, Bornhäuser M, Schaich M, Schetelig J, Platzbecker U, Röllig C, Heiderich C, Landt O, Ehninger G, Thiede C; Study Alliance Leukemia (SAL). Shayegi N, et al. Among authors: ehninger g. Blood. 2013 Jul 4;122(1):83-92. doi: 10.1182/blood-2012-10-461749. Epub 2013 May 8. Blood. 2013. PMID: 23656730 Free article.

2

Regulation of interferon-gamma gene expression by nuclear factor of activated T cells.

Kiani A, García-Cózar FJ, Habermann I, Laforsch S, Aebischer T, Ehninger G, Rao A. Kiani A, et al. Among authors: ehninger g. Blood. 2001 Sep 1;98(5):1480-8. doi: 10.1182/blood.v98.5.1480. Blood. 2001. PMID: 11520798 Free article.

3

Allogeneic transplantation after reduced conditioning in high risk patients is complicated by a high incidence of acute and chronic graft-versus-host disease.

Schetelig J, Kröger N, Held TK, Thiede C, Krusch A, Zabelina T, Dubiel M, Rick O, Bornhäuser M, Ehninger G, Zander AR, Siegert W. Schetelig J, et al. Among authors: ehninger g. Haematologica. 2002 Mar;87(3):299-305. Haematologica. 2002. PMID: 11869943

4

Determination of alpha-1 acid glycoprotein in patients with Ph+ chronic myeloid leukemia during the first 13 weeks of therapy with STI571.

le Coutre P, Kreuzer KA, Na IK, Lupberger J, Holdhoff M, Appelt C, Schwarz M, Müller C, Gambacorti-Passerini C, Platzbecker U, Bonnet R, Ehninger G, Schmidt CA. le Coutre P, et al. Among authors: ehninger g. Blood Cells Mol Dis. 2002 Jan-Feb;28(1):75-85. doi: 10.1006/bcmd.2002.0493. Blood Cells Mol Dis. 2002. PMID: 11987244

5

Association of specific cytogenetic aberrations with mdr1 gene expression in adult myeloid leukemia and its implication in treatment outcome.

Schaich M, Harbich-Brutscher E, Pascheberg U, Mohr B, Soucek S, Ehninger G, Illmer T. Schaich M, et al. Among authors: ehninger g. Haematologica. 2002 May;87(5):455-64. Haematologica. 2002. PMID: 12010657

6

Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosis.

Thiede C, Steudel C, Mohr B, Schaich M, Schäkel U, Platzbecker U, Wermke M, Bornhäuser M, Ritter M, Neubauer A, Ehninger G, Illmer T. Thiede C, et al. Among authors: ehninger g. Blood. 2002 Jun 15;99(12):4326-35. doi: 10.1182/blood.v99.12.4326. Blood. 2002. PMID: 12036858 Free article.

7

Intensified double induction therapy with high dose mitoxantrone, etoposide, m-amsacrine and high dose ara-C for elderly acute myeloid leukemia patients aged 61-65 years.

Schaich M, Illmer T, Aulitzky W, Bodenstein H, Clemens M, Neubauer A, Repp R, Schäkel U, Soucek S, Wandt H, Ehninger G; SHG AML96 Study Group. Schaich M, et al. Among authors: ehninger g. Haematologica. 2002 Aug;87(8):808-15. Haematologica. 2002. PMID: 12161356 Clinical Trial.

8

CD34+-enriched peripheral blood progenitor cells from unrelated donors for allografting of adult patients: high risk of graft failure, infection and relapse despite donor lymphocyte add-back.

Bornhäuser M, Platzbecker U, Theuser C, Hölig K, Ehninger G. Bornhäuser M, et al. Among authors: ehninger g. Br J Haematol. 2002 Sep;118(4):1095-103. doi: 10.1046/j.1365-2141.2002.03731.x. Br J Haematol. 2002. PMID: 12199791 Free article. Clinical Trial.

9

MDR1 gene polymorphisms affect therapy outcome in acute myeloid leukemia patients.

Illmer T, Schuler US, Thiede C, Schwarz UI, Kim RB, Gotthard S, Freund D, Schäkel U, Ehninger G, Schaich M. Illmer T, et al. Among authors: ehninger g. Cancer Res. 2002 Sep 1;62(17):4955-62. Cancer Res. 2002. PMID: 12208746

10

Kinetics of stem cell engraftment and clearance of leukaemia cells after allogeneic stem cell transplantation with reduced intensity conditioning in chronic myeloid leukaemia.

Kreuzer KA, Schmidt CA, Schetelig J, Held TK, Thiede C, Ehninger G, Siegert W. Kreuzer KA, et al. Among authors: ehninger g. Eur J Haematol. 2002 Jul;69(1):7-10. doi: 10.1034/j.1600-0609.2002.01761.x. Eur J Haematol. 2002. PMID: 12270056

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

813 results

Search Page